6R-BH4 Pulmonary Arterial Hypertension Study
NCT00435331
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
sapropterin dihydrochloride (6R-BH4)
Sponsor
Vanderbilt University
Collaborators
[object Object]
[object Object]